Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mia Lohmann"'
Autor:
Thomas Ziegenhals, Ronja Frieling, Philipp Wolf, Katharina Göbel, Stina Koch, Mia Lohmann, Markus Baiersdörfer, Stephanie Fesser, Ugur Sahin, Andreas N. Kuhn
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Introduction: Exogeneous messenger ribonucleic acid (mRNA) can be used as therapeutic and preventive medication. However, during the enzymatic production process, commonly called in vitro transcription, by-products occur which can reduce the therapeu
Externí odkaz:
https://doaj.org/article/cb043fdb9f8c4415a1911c2e6e3bab04
Autor:
Jan-Michel Heger, Julia Mattlener, Laman Mammadova, Sophia Sobesky, Melita Cirillo, Janine Altmüller, Elisabeth Kirst, Sarah Reinke, Wolfram Klapper, Paul J Bröckelmann, Justin Ferdinandus, Roland T Ullrich, Max Freihammer, Sabine Awerkiew, Mia Lohmann, Florian Klein, Peter Nürnberg, Michael Hallek, Andreas Engert, Peter Borchman, Bastian von Tresckow, Sven Borchmann
Publikováno v:
HemaSphere, Vol 7, p e8618132 (2023)
Externí odkaz:
https://doaj.org/article/79607bef1f9e47c8b135e818f59cfcd8
Autor:
Reinhard Büttner, Khosro Hekmat, David Kirsch, Michael Hallek, Birgit Gathof, Jana Fassunke, Asmae Gassa, Hakan Alakus, Sven Borchmann, Carolin Selenz, Mia Lohmann, Hanna Ludwig, Johannes Brägelmann, Philipp Lohneis, Lydia Meder, Julia Mattlener, Sara Breid, Marieke Nill, Amy J. Wisdom, Anik Compes, H. Christian Reinhardt, Roland T. Ullrich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Single-agent immunotherapy has shown remarkable efficacy in selected cancer entities and individual patients. However, most patients fail to respond. This is likely due to diverse immunosuppressive mechanisms acting in a concerted way to s
Externí odkaz:
https://doaj.org/article/3195db6b915d4f2596d994cb921be8a5
Autor:
Laman Mammadova, Jan-Michel Heger, Julia Mattlener, Sophia Sobesky, Melita Cirillo, Paul J. Bröckelmann, Janine Altmüller, Elisabeth Kirst, Stefanie Kreissl, Mia Lohmann, Peter Nürnberg, Andreas Engert, Peter Borchmann, Bastian Von Tresckow, Sven Borchmann
Publikováno v:
HemaSphere, Vol 6, Pp 17-18 (2022)
Externí odkaz:
https://doaj.org/article/03d66c3bacce433a8541c5bb4bfb7d6b
Autor:
Mia Lohmann, Iris Buchberger, Anna Beielstein, Başak Kaçar, Julia Mattlener, Marieke Nill, Zhiyuan Shi, Jan-Michel Heger, Christian Pallasch, Roland Ullrich, Sven Borchmann
Publikováno v:
HemaSphere, Vol 6, Pp 21-21 (2022)
Externí odkaz:
https://doaj.org/article/ee6db555e7d143789e84c78809041af2
Autor:
Sven Borchmann, Carolin Selenz, Mia Lohmann, Hanna Ludwig, Asmae Gassa, Johannes Brägelmann, Philipp Lohneis, Lydia Meder, Julia Mattlener, Sara Breid, Marieke Nill, Jana Fassunke, Amy J. Wisdom, Anik Compes, Birgit Gathof, Hakan Alakus, David Kirsch, Khosro Hekmat, Reinhard Büttner, H. Christian Reinhardt, Michael Hallek, Roland T. Ullrich
BackgroundSingle-agent immunotherapy has shown remarkable efficacy in selected cancer entities and individual patients. However, most patients fail to respond. This is likely due to diverse immunosuppressive mechanisms acting in a concerted way to su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffce8a9976a1567d1be969cb128ee15
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85139753206
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85139753206